Zhitong Finance App News, Cinda Biotech (01801) announced that from September 1, 2026, Mr. Xi Hao will be transferred from an executive director to a non-executive director because he wants to retire from his full time position to spend more time with his family. Mr. Xi has also resigned as his authorized representative in accordance with section 3.05 of the Hong Kong Stock Exchange Limited securities listing rules. Mr. Xi will continue to serve as a member of the Board's Strategy Committee.

Mr. Xi has resigned as authorized representative, and Dr. Yu Dechao has been appointed as authorized representative with effect from September 1, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.